Dental Lasers Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Dental lasers are considered devices that emit coherent light beams, mainly suited to perform oral surgeries. These lasers prevent the need for surgical instruments like coherent light beams, coherent light beams, and handpieces. Dental lasers also offer benefits like less contamination, less trauma, and less bleeding and are being accepted across the globe due to their ability like short healing time, lower light exposure, portability, and does not require anesthesia. The global dental lasers market, as per a report by Market Research Future (MRFR) is touted to register a healthy CAGR of 5.2% during the assessment period (2017-2023).

The increasing number of dental disorders among the global population and surging awareness associated with oral hygiene is considered the key growth stimulants of the dental lasers market. Innovations made in treatment technologies and dental disorders diagnostics are estimated to offer the market a thrust. Advantages like reduced need for sutures and minimized bleeding are likely to encourage the market growth across the globe.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7375 

The rising spending on cosmetic dentistry is predicted to trigger the demand for dental laser equipment. Cosmetic dentistry is experiencing significant growth, especially in developed countries like Europe and North America owing to the high disposable income. As the aging population is prone to tooth decay and gum diseases, the surge in geriatric population suffering from dental disorders will further encourage the market growth in the foreseeable future.

On the contrary, dental lasers are expensive compared to their substitutes like dental drills, which is estimated to deter the market growth.

Global Dental Lasers Market: Segmental Analysis

The dental lasers market has been segmented on the basis of application, product, and end users.

By product, the dental lasers market is segmented into all tissue dental lasers and soft tissue dental lasers. Of these, the soft tissue dental lasers segment will expand at a significant pace due to rising incidences of soft tissue disorders like gingivitis periodontal disorders.

The application segment comprises oral surgery, endodontic treatment, peri-implantitis, implantology, periodontics, and others. Of these, the periodontics segment will gain prominence due to the surging number of periodontics and increasing the spending power of the consumers.

The end users’ segment is segmented into ambulatory surgical units, hospitals & clinics, and academic & research organizations. Of these, the hospitals & clinics segment will gain prominence owing to the high availability of specialized physicians. Increased preferences for diagnosis and treatment at the clinics will further augment the market growth in the segment.

Regional Frontiers

Geographically, the dental lasers market spans across Europe, Asia Pacific, North America, and the Middle East & Africa.

Considering the global scenario, North America is estimated to acquire the lion’s share and dominate the market, mainly due to the surging cases of dental diseases and increased expenditure on healthcare. As per a study by the National Institute of Dental & Craniofacial Research, around 92% of the adults are predicted to suffer from dental diseases. The existence of developed countries like Canada and the U.S. are further likely to influence the market growth in the region.

Europe bags the second spot with 30%-35% of the total market share. The growth of the regional market can be ascribed to the high dental healthcare expenditure, surging penetration of the market players, and increased government support for the dental sector.

The Asia Pacific is estimated to expand at a rapid pace due to the surging geriatric population, increased preferences for minimally invasive surgeries, and soaring awareness regarding dental lasers. The rapid boom in the dental industry has made the region lucrative for market expansion and development. The rising awareness regarding the guaranteed treatment of dental lasers has further encouraged the market growth. In this region, India is likely to experience significant growth due to surging number of dental diseases caused due to high consumption of alcohol, tobacco, and other products. Surging demand for cosmetic dentistry, coupled with the rising medical tourism will propel the market growth in the APAC.

Industry Updates

September 2019: LBP Optics, a supplier of infrared optics and laser mirrors for laser cutting and welding, research and development, military and defense systems, medical and dental lasers, and other, has recently declared that the company has purchased Symons Mirror Technology. The acquisition will enable LBP Optics to manufacture complex shapes like axicons, polygons, aspheric, infrared domes, and others.

Competitive Dashboard

The top players operating in the dental lasers market include Biolase, Inc., AMD Lasers, Convergent Dental, Inc., Cao Group, Inc., Fotona D.D., Danaher Corporation- Kavo Dental GmbH, Millennium Dental Technologies, Inc., Ivoclar Vivadent AG, Syneron Dental Lasers-Syneron Medical Ltd., Sirona Dental Systems, Inc., Zolar Technology & MFG. Co. Inc., and The Yoshida Dental MFG. Co., Ltd.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dental-lasers-market-7375 

Veterinary Laboratory Testing Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 The global veterinary laboratory testing market is anticipated to grow at a 10.1% CAGR between 2018-2023, states the new Market Research Future (MRFR) report. Veterinary laboratory testing is the test that is carried out to detect a disease in any animal. The tests are done by collecting tissue samples, feces, and blood of the animal. 

Numerous factors are pushing the growth of the veterinary laboratory testing market. Such factors, according to the new Market Research Future report, include the rise in adoption of pets, favorable funding policies, advancements in healthcare facilities, rising number of veterinary practitioners, rising expenditure on pet insurance, increasing disposable income, and rising prevalence of zoonotic diseases. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7326 

On the contrary, lack of awareness regarding veterinary laboratory testing, complications related to the tests, and the high price of veterinary testing are factors that may restrict the veterinary laboratory testing market growth during the forecast period. 

Market Segmentation 

The Market Research Future report offers a complete segmental analysis of the global veterinary laboratory testing market based on end user, product, animal type, and technology. 

By animal type, the veterinary laboratory testing market is segmented into livestock animal and companion animal. The livestock animal segment is again segmented into poultry, pigs, cattle, and others. The companion animal segment is again segmented into horses, cats, dogs, and others. 

By technology, the veterinary laboratory testing market is segmented into urinalysis, molecular diagnostics, hematology, immunodiagnostics, clinical biochemistry, and others. The urinalysis segment is again segmented into urine test strips, urine analyzers, and urinalysis clips and panels/cartridges. The molecular diagnostics segment is again segmented into microarrays, polymerase chain reaction (PCR) tests, and others. The hematology segment is again segmented into hematology analyzers and hematology cartridges. The immunodiagnostics segment is again segmented into immunoassay analyzers, allergen-specific immunodiagnostic tests, lateral flow assays, ELISA tests, and others. The lateral flow assays segment is further segmented into lateral flow strip readers and lateral flow rapid tests. The clinical biochemistry segment is again segmented into blood gas & electrolyte analysis, glucose monitoring, and clinical chemistry analysis. The chemistry analysis segment is further segmented into chemical chemistry analyzers and clinical reagent clips & cartridges. The glucose monitoring segment is further segmented into urine glucose strips, glucose monitors, and blood glucose strips. The blood gas & electrolyte analysis segment is further segmented into blood gas and electrolyte analyzers and blood gas & electrolyte reagent chips and cartridges. 

By product, the veterinary laboratory testing market is segmented into instruments and consumables. 

By end user, the veterinary laboratory testing market is segmented into diagnostic laboratories, research institutes, in-house testing, hospitals and clinics, and others. 

Regional Analysis 

By region, the global veterinary laboratory testing market report covers the latest trends and growth opportunities across North America, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will remain the driving force in the market during the forecast period. Numerous factors are propelling the growth of the global veterinary laboratory testing market in this region such as advancements in technology in veterinary diagnostics, rising cases of animal disease, growing awareness about laboratory-based diagnostic for pets, and burgeoning demand for animal diagnostic tests that are laboratory-based. 

The global veterinary laboratory testing market in Europe will hold the second-largest share in the market. Numerous factors are propelling the growth of the global veterinary laboratory testing market in this region, such as increasing expenditure on pet insurance, increasing awareness about veterinary laboratory testing, and numerous technological advancements. 

The global veterinary laboratory testing market in the Asia Pacific region will grow at the fastest pace during the forecast period for a huge number of animals, especially goat, buffalo, and cow suffering from different diseases. 

The global veterinary laboratory testing market in the MEA will have favorable growth during the forecast period for the burgeoning demand for veterinary diagnostic equipment that is cost-effective. 

Key Players

Notable players profiled in the global veterinary laboratory testing market report include Zoetis, Inc., Virbac, VCA Inc., Thermo Fisher Scientific, Randox Laboratories, Ltd., Qiagen N.V., Pfizer, Neogen Corporation, Idvet, Idexx Laboratories, Heska Corporation, Henry Schein, Inc., Biomérieux SA, BIOCHECK Inc., and Abaxis, Inc. Key players have incorporated specific strategies to stay head and shoulders above others in the competition, such as collaborations, mergers and acquisitions, new product launches and innovations, research and development activities, joint ventures/partnerships, and more. 

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/veterinary-laboratory-testing-market-7326 

Sleep Testing Services Market Growth, Trends and Value Chain 2020-2027

 The global sleep testing services market is anticipated to hold a market value of USD 5.9 billion in the year 2017 and is expected to grow at a CAGR of 13.2% during the forecast period. Sleep testing services are used to diagnose sleep disorders by recording heart rate, breathing patterns, brain waves, eye movements, leg movements, etc.

Rising prevalence of sleep disorders, increasing awareness about sleep testing services and technological advancements related to sleep testing services are expected to drive the growth in the market over the forecast period. According to an article published in the Psychiatry Research magazine by Science Direct published in July 2018, global prevalence of restless leg syndrome (a sleep disorder) is 14.8%.  However, high costs of the sleep testing services can restrain the market growth over the assessment period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7275 

Regional Analysis

Geographically, the Americas is expected to dominate the global market owing to the high prevalence of various sleep disorders, rising awareness about the sleep testing services. According to an article published by the National Institute of Neurological Disorders and Stroke in July 2018, 135,000 to 200,000 people in the US are affected by narcolepsy, which is a disorder that affects the sleep-wake cycle of a person. Europe is expected to hold the second largest position in the global market owing to the increasing awareness about sleep testing services. Asia-Pacific is expected to be the fastest growing market owing to the rising prevalence of sleep disorders like insomnia, restless leg syndrome, etc. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.

Segmentation

The global sleep testing services market has been segmented into diagnostic services, treatment monitoring services and end user.

The market, on the basis of diagnostic services, has been segmented into home sleep testing and in-lab sleep testing. In-lab sleep testing is further segmented into electroencephalogram, full polysomnography, CPAP/BiPAP Titration, multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT).

The global market, on the basis of treatment monitoring services, has been segmented into obstructive sleep apnea, insomnia, restless legs syndrome, circadian rhythm disorders, narcolepsy and rapid eye movement (REM) sleep disorder.

The global sleep testing services market, by end user, has been segmented into hospitals, sleep centers, home care settings and others. The hospitals segments is expected to hold the largest market share owing to high preference of people visiting the hospitals for treating their disorders. Whereas the sleep centers are expected to grow at the fastest market share owing to increasing awareness among patients regarding the sleep centers.

Key Players

Some of the prominent players in the global sleep testing services market are St. Luke's, Medical Service Company, Midwest Sleep Diagnostics, Inc., Sleep Services Australia, Total Sleep Holdings, Inc., GenesisCare, Carolinas Sleep Services, SleepMed, SOVA Sleep Services, SleepWorks, LLC, HomeSleep, LLC and Others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/sleep-testing-services-market-7275 

Substance Abuse Treatment Market – Functional Survey 2027

 Market Overview

Market Research Future (MRFR) believes that the substance abuse treatment market can capture a healthy growth rate of 11.6% over the analysis period (from 2018 to 2023).

Primary Boosters and Challenges

Alcohol consumption, smoking and drug use are some of the most common practices worldwide, given the easy access to these products, lower government restrictions as well as authorized production. The World Health Organization says that over 3 million deaths every year are the result of excessive intake of alcohol. Addiction to drugs, tobacco and alcohol has also been rising among teenagers and women in line with evolving lifestyle and easy availability. A number of researches show that close to 50 disorders are associated with over consumption of these substances, including liver cirrhosis, cancer, depression, immune suppression and dementia. The rise in these disorders across the world has raised the demand for effective substance abuse treatment options.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7230 

The Clinical and Translational Investigation journal’s report in 2015 claimed that over 60% of smokers begin smoking at 13 years of age while more than 90% of the total population starts before they reach 20 years of age. Sensing the burgeoning numbers of substance abusers across the countries, pharmaceutical firms are launching new drugs that help curb the craving among patients. Disulfiram happens to be one of the earliest drugs in the market that controls the acetaldehyde dehydrogenase enzyme and is widely used in alcohol abuse treatment.

Other growth rendering factors include technological innovations in the diagnostics sector, soaring awareness among patients about the available treatment options and the surge in treatment rates as well as improving healthcare infrastructure.

Market Segmentation

The market for substance abuse treatment has been studied extensively in the MRFR report, which has covered a few major segments including abuse type, treatment type and end user.

The various abuse types highlighted in the MRFR study include tobacco/nicotine addiction, drug abuse and alcohol dependence. The largest market is for drug abuse, in view of the surging addiction to opioid among the global population. Drug abuse has emerged as a huge concern in emerging countries like Mexico, Brazil and China, where substance abuse treatment options are in high demand.

Depending on treatment type, the market caters to tobacco/nicotine addiction treatment, drug abuse treatment and alcohol addiction treatment. Tobacco/nicotine addiction market is currently in the lead, owing to the high availability of various types of over-the-counter nicotine replacement products along with the escalating use of prescription opioids as well as illicit drugs.

Residential treatment centres, inpatient treatment centres and outpatient treatment centres are the key market end-users listed in the report. Outpatient treatment centers are witnessing highest preference among the patients, considering the lower costs, higher availability of these services, and the significant convenience.

Regional Status  

Asia Pacific/APAC, Americas, MEA or Middle East & Africa and Europe are the key markets for substance abuse treatment worldwide.

The Americas is spearheading the global market for substance abuse treatment, in view of the soaring number of drug awareness campaigns as well as prevention programs. These campaigns cover spreading awareness among patients to boost the treatment-seeking rate. Rising government intervention with significant funds and initiatives to control distribution of illicit drugs and other substances also favor the regional market. Other growth enhancing factors include burgeoning population of substance abusers and the surge in technical advancements.

Asia Pacific shows the potential to attain the fastest growth rate in the years to come, thanks to the growing efforts by several countries to deal with mounting concerns regarding drug and alcohol abuse. Moreover, government across various countries are spending considerably on promotional campaigns to prevent and treat addiction. Surge in tobacco addiction coupled with the rise in technical advances also elevate the market position in the region. Alcohol dependency and opioid abuse are quite rampant in the region, especially among the lower-class population while mental health issues have become major concerns. This is bound to create a lucrative scenario for the substance abuse treatment market in the coming years.

Eminent Firms

The affluent firms in the global market for substance abuse treatment include Teva Pharmaceuticals, Accord Healthcare, Alkermes Plc, LFB Group, Sanofi Aventis, Mylan Laboratories, Pfizer Inc., Forest Laboratories, Inc., Purdue Pharma LP, Amphastar Pharmaceuticals, Reckitt Benckiser Pharmaceuticals, GlaxoSmithKline Plc., Allergan, Cipla, INSYS Therapeutics, Sun Pharmaceuticals, Lupin, Opiant Technologies, Apotex, Sanquin, BioCorRx, Glenmark, Sterinova, to list a few.

Latest News

March 2021

Atai Life Sciences and DemeRx have been given the green signal by the UK Medicines and Healthcare products Regulatory Agency or MHRA to begin enrolling for a Phase I/II study of ibogaine HCl, which helps with the treatment of opioid use disorder. Atai Life Sciences has invested close to USD 22 million in the joint venture for the development of the psychedelic, which ensures sustained and rapid efficacy in treating OUD.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/substance-abuse-treatment-market-7230 

Medication Management Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

 Market Insights

Market Research Future predicted that the global medication management market is set to reach the highest CAGR of 13.4% through the forecast period, 2018-2023.

Medication management focuses on improving medication use for the patient's condition. Interventions may include medication alignment, medication management, patient / family education about medications, and patient medication configuration simulations.

The growing geriatric population is one of the most important factors in the drug management market. Older people often have significant comorbidities that increase drug use and the risk of poor outcomes. According to a 2018 study published in Clinical Epidemiology, polypharmacy affects between 40% and 50% of older people in countries with high-income. Polypharmacy increases the risk of drug-related side effects in older people because more drugs are associated with a higher risk of harmful drug interactions. Several other factors, such as the emergence of funds in the healthcare sector and the need to reduce healthcare costs, are some of the drivers of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7187 

However, the high costs of software implementation and service maintenance can hinder the market growth during the forecast period.

Market Segmentation

The global drug management market is segmented based on systems, services, delivery methods, and end-user.

The global system-based medication management market is divided into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems, and assurance systems. Administration software segment is further classified as Bar Code Drug Delivery Software (BCMA) and Electronic Drug Management Software (eMAR). The automatic distributor's segment is further classified as centralized automated distribution systems and decentralized automated distribution systems (ADS). A centralized automated dosing system includes robots / dosing systems and automated carousels. The decentralized automated dispensing system (ADS) comprises automated decentralized unit dose metering systems, pharmacy-based decentralized automated dispensing systems, and service-based decentralized automated dispensing systems.

The services market segment is subdivided into point-of-care verification services and drug side effects monitoring.

The global market, on the basis of delivery mode, is divided into on-premise solutions, web-based solutions, and cloud-based solutions.

The market is segmented into pharmacies, hospitals, healthcare facilities, research institutes, and others, based on end-user.

Regional Outlook

The United States has dominated the global drug management market. This growth can be ascribed to the rise in the elderly population and the presence of the main market players in the region.

Europe ranked second in 2017 due to the presence of developed economies such as the United Kingdom, Germany, France, and other countries in the region, which is an engine for market growth.

The Asia Pacific region is likely to see the fastest growth in 2017. Factors such as health technology sector growth, increasing market penetration in the region, and growing government support for foreign investment provide regional markets in the region. Asia Pacific.

In addition, the Middle East and Africa had the lowest share of the global drug management market due to the existence of low per capita income and poor economies, especially in the African region. The Middle East region is considered an important market for the Middle East and Africa region.

Major Players

The leading players that are supporting the functioning of the global medication management market include General Electric Company, Siemens Ltd, Medical Information Technology, QuadraMed Affinity Corporation, Allscripts Healthcare Solutions, Cerner Corporation, Mckesson Corporation, Omnicell, Inc., Carefusion Corporation, Epic Systems Corporation, and Optum Inc.

Recent Updates

Omnicell, Inc., a leading of medication management solutions for healthcare and pharmacy systems, has announced that Mercy, one of five US healthcare systems for Oklahoma, Arkansas, Missouri, and Kansas, will take over the management of medication in your service network through its Omnicell's automation and intelligence solutions. Omnicell works with major healthcare systems, such as Mercy, and the company launches its vision for independent pharmacies, a step-by-step plan for developing a fully automated zero-error drug management infrastructure. Based on automation, data intelligence, and specialized services, the autonomous pharmacy will allow pharmacists, nurses, physicians, and pharmacist staff to focus on patient and physician satisfaction.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medication-management-market-7187 

Clinical Laboratory Services Market Is Seeing Explosive Growth by Future Industry Winners: Forecast, 2020-2027

 The global clinical laboratory services market is on track to score past USD 274,400 million by 2023, with an impressive CAGR during the forecast period engulfing 2018 to 2023. Market Research Future (MRFR) includes several possible factors like the growing demand for advanced technologies, proper support from the healthcare funding, initiatives to inspire better growth of the market, the prevalence of chronic diseases, rising pressure on the pharmaceutical sector to develop drugs, a surge in demand for better diagnosis, and others as major thrust providers. Due to the recent COVID-19 crisis, the market is set to benefit more as the demand for finding a proper vaccine and drug is growing. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7145 

Segmentation:

The segmental analysis of the clinical laboratory services market leads to segmentation based on type and application. MRFR’s recording of this segmentation uncovers data that has been backed by graphs and charts, and it could influence the strategy-making policies in the future.

By type, the report on the clinical laboratory services market encompasses endocrinology, microbiology, genetic testing, biochemistry, histopathology, cytology, hematology, and others. The hematology segment has the maximum market share and in 2017, the valuation was USD 53,869 Mn. The segment is now projected to rise with a CAGR of 3.31% during the forecast period. It includes coagulation screening, antibody screening, automated blood counting and morphological profiling, specialist hemostasis, blood grouping, and hemoglobinopathy investigations. 

By application, the study of the global clinical laboratory services market includes reference laboratory, independent laboratory, and hospital laboratory. The hospital laboratory segment has two-third of the total market share. It would retain its position during the forecast period with the independent laboratory segment trailing behind. Better research facilities and scope for including results into treatments are expected to boost this segment’s growth.

Regional Analysis:

The Americas is expected to inspire changes in the market as their structural advantages and influx of fund are providing a substantial tailwind to the regional market. Among countries, the US and Canada would definitely inspire better changes. In Europe, the market will witness similar changes with countries like Italy, France, Germany, and the UK leading the rush. 

Competitive Landscape:

Mayo Medical Laboratories, Laboratory Corporation of America Holdings, Bio-Reference Laboratories, Spectra Laboratories Inc, Unilabs, Adicon Clinical Laboratory, Amedes Holdings, Clinical Reference Laboratory, Quest Diagnostics Incorporated, Lifelabs Medicals Laboratories, ACM Medical Laboratory, Synlab International, Cerba Healthcare, Eurofins Scientific, and Sonic Healthcare are some of the prominent companies making significant changes in the global market to ensure the market stays on its course towards growth. These companies have invested substantial amounts in research and development projects and to achieve that, they often get involved in various mergers and acquisitions. In fact, collaborations also provide ample opportunities. This leads to better innovations and inspires growth in brand value. MRFR covers these recent events to understand what’s trending and how much that can impact the market. 

Industry News:

In June 2020, Solvias, a name to reckon with as a global provider of development, contract research, and manufacturing services, inked a deal with the strategic health care investors like Water Street Healthcare Partners and JLL Partners, to ensure the growth of Solvias through total acquisition and investment. This agreement is expected to make Solvias a global leader and ease the [ercolation of the company in the pharmaceutical laboratory services segment. This will also ensure the growth of the clinical laboratory services market.

In June 2020, the Zamboanga del Sur provincial government offered to initiate free clinical laboratory services and consultation for all the government employees to ensure they maintain a proper health standard and lead a healthy life.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/clinical-laboratory-services-market-7145 

Surgical Drapes and Gowns Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

 Surgical drapes and gowns are non-woven disposable apparel used in hospitals and clinics to prevent the transmission of germs and bacteria. The protective gear can be worn and reused after multiple washes while maintaining sterility of surfaces. The global surgical drapes and gowns market report by Market Research Future (MRFR) looks at the need for medical nonwoven disposables, its prospects for the period of 2018 to 2023 (forecast period), and its standing amid the COVID-19 pandemic.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7122 

Market Scope

The global surgical drapes and gowns market is expected to grow significantly over the forecast period by exhibiting a 4.4% CAGR. It held a value of USD 2.23 billion in 2017. The incidence of hospital-acquired infections (HAIs) which led to the transmission of various diseases such as HIV has triggered the need for the medical gear. Large number of surgeries has induced the need for drapes and gowns among surgeons and ancillary hospital staff. The large expenditure allocated to the healthcare sector and technological breakthroughs focused on comfort and security are expected to foster market growth. Initiatives on developing gowns with cotton polyester mixes and barriers for prevention of liquid repellents can create growth opportunities for the market.

But lack of funds in public hospitals and stringent rules for product approval of medical clothing can hamper market growth.

Segmentation

The global surgical drapes and gowns market has been segmented into type, usage pattern, and end user.

Based on type, surgical drapes and gowns market is segmented into surgical drapes and surgical gowns. The surgical drapes segment is expected to account for the largest share of the market in 2017. This can prevent the transfer of infectious diseases to patients and doctors.

Based on usage pattern, surgical drapes and gowns market is segmented into disposable surgical drapes & gowns and reusable surgical drapes & gowns. Disposable surgical drapes and gowns can capture a large market share owing to its adoption by private and public hospitals, regulations promoting doctor safety, and their potential in controlling infection numbers.

Based on end user, the global surgical drapes and gowns market is segmented into hospitals, ambulatory surgical centers, and others. Hospitals accounted for a large market share in 2017 owing to a large portion of surgeries taking place at these facilities.

Regional Analysis

The surgical drapes and gowns market segmented, by region, into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

Geographically, the Americas is anticipated to dominate the global surgical drapes and gowns market owing to well-established producers, large hospital chains, modern healthcare infrastructure, and a surge in surgical procedures. The U.S. has a large patient pool, reimbursement schemes covering surgeries, and prevalence of accidents and injuries.

Europe is expected to hold the second largest position in the global surgical drapes and gowns market. The market growth in this region is attributed to the growth in surgical procedures.

APAC is set for an explosive growth as the population increases in economies of China and India and need for personal protective equipment (PPE) kits. Development of healthcare infrastructure and the classification of surgical gowns by federal bodies can lead to its commercialization.

Lastly, the MEA region has the least share of the surgical drapes and gowns market.

Competitive Outlook

Halyard Health, STERIS Corporation, Guardian, Thermo Fisher Scientific, Mölnlycke Health Care, Medica Europe B.V., 3M, Cardinal Health, Paul Hartmann AG, and Pacon Manufacturing are prominent names in the global surgical drapes and gowns market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-drapes-and-gowns-market-7122